Neuropathological Verisimilitude in Animal Models of Alzheimer’s Disease : Key to Elucidating Neurodegenerative Pathways and Identifying New Targets for Drug Discovery

Por Trojanowski, John Q.
Publicado em 2002

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Por Trojanowski, John Q
Publicado em 2013

Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention

Por Trojanowski, John Q., Hampel, Harald
Publicado em 2011

Use of Alzheimer Disease Biomarkers: Potentially Yes For Clinical Trials but Not Yet for Clinical Practice

Por Petersen, Ronald C., Trojanowski, John Q.
Publicado em 2009

Many roads to Parkinson’s disease neurodegeneration: Head trauma- A road more traveled than we know?

Por Irwin, David J., Trojanowski, John Q.
Publicado em 2013

Primary or secondary prevention for AD: who cares?

Por Frisoni, Giovanni B, Trojanowski, John Q
Publicado no Lancet Neurol (2012)

The Alzheimer’s Brain : Finding Out What’s Broken Tells Us How to Fix It

Por Trojanowski, John Q., Lee, Virginia M.-Y.
Publicado em 2005

Biomarkers in Frontotemporal Lobar Degenerations – Progress and Challenges

Por Hu, William T., Trojanowski, John Q., Shaw, Leslie M.
Publicado em 2011

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease

Por Irwin, David J., Trojanowski, John Q., Grossman, Murray
Publicado em 2013

Alzheimer’s disease biomarkers: walk with deliberate haste, don’t run blithely on?

Por Hu, William T., Shaw, Leslie M., Trojanowski, John Q.
Publicado em 2013

TDP-43: A Novel Neurodegenerative Proteinopathy

Por Forman, Mark S, Trojanowski, John Q, Lee, Virginia M-Y
Publicado em 2007

Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies

Por Geser, Felix, Lee, Virginia M.-Y., Trojanowski, John Q.
Publicado em 2010

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker

Por Toledo, Jon B, Shaw, Leslie M, Trojanowski, John Q
Publicado em 2013

Therapeutic strategies for tau mediated neurodegeneration

Por Yoshiyama, Yasumasa, Lee, Virginia M Y, Trojanowski, John Q
Publicado em 2012

Neuron-Specific Age-Related Decreases in Dopamine Receptor Subtype mRNAs

Por HEMBY, SCOTT E., TROJANOWSKI, JOHN Q., GINSBERG, STEPHEN D.
Publicado em 2003

Protein astrogliopathies in human neurodegenerative diseases and aging

Por Kovacs, Gabor G., Lee, Virginia M., Trojanowski, John Q.
Publicado no Brain Pathol (2017)

Physical Activity and Cognitive Health

Por Jedrziewski, M. Kathryn, Lee, Virginia M.-Y., Trojanowski, John Q.
Publicado em 2007

Advances in Tau-focused drug discovery for Alzheimer's disease and related tauopathies

Por Brunden, Kurt R., Trojanowski, John Q., Lee, Virginia M.-Y.
Publicado em 2009

Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis

Por Pesiridis, G. Scott, Lee, Virginia M.-Y., Trojanowski, John Q.
Publicado em 2009

Evidence That Non-Fibrillar Tau Causes Pathology Linked To Neurodegeneration And Behavioral Impairments

Por Brunden, Kurt R., Trojanowski, John Q., Lee, Virginia M-Y.
Publicado em 2008